Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients
Editorial Group: Cochrane Stroke Group
Published Online: 7 OCT 2009
Assessed as up-to-date: 12 JUL 2009
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Sudlow CLM, Mason G, Maurice JB, Wedderburn CJ, Hankey GJ. Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD001246. DOI: 10.1002/14651858.CD001246.pub2.
- Publication Status: New search for studies and content updated (no change to conclusions)
- Published Online: 7 OCT 2009
This article has been cited by:
- 2Combination therapy with warfarin plus clopidogrel improves outcomes in femoropopliteal bypass surgery patients, Journal of Vascular Surgery, 2012, 56, 1, 96, , , , , ,
- 3Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events, The Lancet Neurology, 2010, 9, 3, 273, ,